Testimonies from the Trenches Series - Buprenorphine in Residential Treatment Settings (On-Demand)
Recorded On: 01/13/2022
Testimonies from the Trenches: Innovations in Clinical Practice -
Buprenorphine in Residential Treatment Settings.
This is a 30 minute didactic presentation with (.5 CME). This presentation is a description of Buprenorphine as used in an inpatient residential treatment center. It will guide the practitioner through detox, inpatient care and the eventual discharge and post-discharge planning.
This webinar is free to AOAAM members.
Non-members at $25. Consider membership!
- Understand the Options of Medicated Assisted Treatment (MAT) for Opioid Use Disorders
- To create a framework for guiding a patient to the appropriate MAT
- Detox and Induction of Buprenorphine
- Post Discharge referrals
- A comfort level on when and how to begin Buprenorphine in detox. (competence, performance)
The process of making the best decision for an individual patient's MAT (competence, performance and patient outcomes)
A look at the many factors that are involved in this process (competence)
CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.
Michael McCormick, DO
Michael A. McCormick, D.O., is the medical director of the Healthcare Professionals Program, a role he took on in January 2020, after serving as the addiction medicine provider for the program since its inception in 2016. He also leads Caron's Healthcare Professionals Assessment Program and provides daily care to the in-patient healthcare participants. As the physician in charge of the Opioid Treatment Program, he cares for patients who suffer from a particularly deadly disease, helping them with medication-assisted treatment decisions and induction of treatment.
Employed by Richard J Caron Foundation
Jon Lepley, DO (Moderator)
AOAAM President Elect
Jon Lepley, DO received his medical degree from Lake Erie College of Osteopathic Medicine and he completed his Family Medicine residency training at Heart of Lancaster Regional Medical Center. He is Board Certified by the American Osteopathic Board of Family Physicians, with a Certificate of Added Qualifications in Addiction Medicine. He is a Diplomate of the American Board of Addiction Medicine and he is recognized as a Certified Correctional Health Professional by the National Commission on Correctional Health Care. He has been conferred Fellow status by the American Society of Addiction Medicine.
Dr. Lepley spent many formative years of practice providing healthcare within the Philadelphia Department of Prisons, wherein he pioneered a program which provides Medication Assisted Treatment to individuals suffering from opioid use disorder. His work in Philadelphia has been recognized by the College of Physicians of Philadelphia Section of Public Health and his program has been presented on a national level, garnering interest from large correctional systems across the country. Dr. Lepley’s clinical interests also include recognition of physician impairment and promotion of physician wellness. In this regard, he volunteers his time to serve on an Advisory Committee for the Pennsylvania Physician Health Program. His current professional role is with Penn Medicine as Medical Director of Addiction Medicine for the Lancaster General Health system.